NCT06760572 Airway Data Collection With the Entarik Feeding Tube System
| NCT ID | NCT06760572 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Theranova, L.L.C. |
| Condition | Healthy |
| Study Type | INTERVENTIONAL |
| Enrollment | 30 participants |
| Start Date | 2025-02-13 |
| Primary Completion | 2025-12-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 30 participants in total. It began in 2025-02-13 with a primary completion date of 2025-12-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to evaluate the airway detection performance of the Entarik Feeding Tube System, and to collect data when the Entarik Feeding Tube is in the Airway for device development.
Eligibility Criteria
Inclusion Criteria: 1. At least 18 years old. 2. Able to provide informed consent. 3. Adults scheduled to undergo a bronchoscopy procedure who will be intubated as part of the standard of care. Exclusion Criteria: 1. Known major upper airway malformation. 2. Presence of clinically significant respiratory infection. 3. Known bleeding disorder. 4. Currently pregnant. 5. Current basilar skull fracture. 6. Known sensitivities or allergies to the feeding tube components. 7. Deemed unsuitable for enrollment in study by the investigator based on subject's history (e.g., active anticoagulation therapy) or physical examination.
Contact & Investigator
Daniel Burnett, MD
STUDY DIRECTOR
Theranova, LLC
Frequently Asked Questions
Who can join the NCT06760572 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Healthy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06760572 currently recruiting?
Yes, NCT06760572 is actively recruiting participants. Contact the research team at clinicalstudy@theranova.com for enrollment information.
Where is the NCT06760572 trial being conducted?
This trial is being conducted at Philadelphia, United States.
Who is sponsoring the NCT06760572 clinical trial?
NCT06760572 is sponsored by Theranova, L.L.C.. The principal investigator is Daniel Burnett, MD at Theranova, LLC. The trial plans to enroll 30 participants.